CANTON, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" and the "Company") today announced that the Company will host a teleconference to update investors and other stakeholders in the Company on a number of business and financial topics. The teleconference is scheduled for Thursday, June 20, 2024 at 4:30pm ET. Topics to be discussed include:
- FY 2023 financial and business results.
- FY 2024 financial and business outlook.
- Status of Company's relocation to its new manufacturing facility.
- Status of Company's new Joint Venture Program.
- Update on Uncle Bud's Health and Wellness
- Product expansion – expected Q3/Q4 2024 release of new nanoemulsified products, including:
- Next Generation Skincare (with nano-retinol).
- Next Generation Nootropic (cognitive/memory enhancer).
- Best-in-Class Nanoemulsified Antioxidant Cocktail for both B2B and DTC sales.
- Placement of 1st Generation UltraShear benchtop equipment into multiple cannabis companies – for brand awareness of fast-acting (3-5 minutes) THC edible products.
Interested stakeholders may listen to the teleconference either live (by telephone) or through a replay (by telephone via a link on the Company's website) approximately one day after the teleconference.
The teleconference will include a Company presentation followed by a Question & Answer period.
Date: Thursday, June 20, 2024. | Time: 4:30 PM Eastern Time. |
To attend this teleconference, live by telephone, ...